Skip to main content
medichelpline
Join Free
Back to Drug Index
General MedicationsTOPICALStandard

IVERMECTIN

IVERMECTIN

Standard Dose
1%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription

Key Takeaways

  • Primary indication: Review priority: STANDARD Marketing status: Prescription
  • Approval overview IVERMECTIN is listed in Drugs@FDA under application 215210 (ANDA).
  • Review priority: STANDARD Marketing status: Prescription Active ingredient IVERMECTIN Form and strength CREAM;TOPICAL - 1% Sponsor ZYDUS LIFESCIENCES Submission history Latest submission status date: 2023-05-08 00:00:00.

Structured Monograph

Clinical summary

Approval overview IVERMECTIN is listed in Drugs@FDA under application 215210 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient IVERMECTIN Form and strength CREAM;TOPICAL - 1% Sponsor ZYDUS LIFESCIENCES Submission history Latest submission status date: 2023-05-08 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.